Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Semin Cell Dev Biol ; 156: 58-65, 2024 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-37438211

RESUMEN

Membrane structural integrity is essential for optimal mitochondrial function. These organelles produce the energy needed for all vital processes, provided their outer and inner membranes are intact. This prevents the release of mitochondrial apoptogenic factors into the cytosol and ensures intact mitochondrial membrane potential (ΔΨm) to sustain ATP production. Cell death by apoptosis is generally triggered by outer mitochondrial membrane permeabilization (MOMP), tightly coupled with loss of ΔΨ m. As these two processes are essential for both mitochondrial function and cell death, researchers have devised various techniques to assess them. Here, we discuss current methods and biosensors available for detecting MOMP and measuring ΔΨ m, focusing on their advantages and limitations and discuss what new imaging tools are needed to improve our knowledge of mitochondrial function.


Asunto(s)
Técnicas Biosensibles , Membranas Mitocondriales , Membranas Mitocondriales/metabolismo , Potenciales de la Membrana , Mitocondrias/metabolismo , Apoptosis/fisiología
2.
Sci Rep ; 14(1): 3768, 2024 02 14.
Artículo en Inglés | MEDLINE | ID: mdl-38355966

RESUMEN

Neuroblastoma (NB) is the most common pediatric tumor and is currently treated by several types of therapies including chemotherapies, such as bortezomib treatment. However, resistance to bortezomib is frequently observed by mechanisms that remain to be deciphered. Bortezomib treatment leads to caspase activation and aggresome formation. Using models of patients-derived NB cell lines with different levels of sensitivity to bortezomib, we show that the activated form of caspase 3 accumulates within aggresomes of NB resistant cells leading to an impairment of bortezomib-induced apoptosis and increased cell survival. Our findings unveil a new mechanism of resistance to chemotherapy based on an altered subcellular distribution of the executioner caspase 3. This mechanism could explain the resistance developed in NB patients treated with bortezomib, emphasizing the potential of drugs targeting aggresomes.


Asunto(s)
Antineoplásicos , Neuroblastoma , Niño , Humanos , Bortezomib/farmacología , Bortezomib/uso terapéutico , Caspasa 3/farmacología , Línea Celular Tumoral , Apoptosis , Neuroblastoma/tratamiento farmacológico , Neuroblastoma/patología , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA